Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)

Journal article

McNaughton AL. et al, (2019), Scientific Reports, 9

Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes

Conference paper

Mcnaughton A. et al, (2018), Journal of Hepatology, 68, S762 - S762

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing

Journal article

van der Ree MH. et al, (2017), Antiviral Research, 146, 139 - 145

Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes

Journal article

Thomson E. et al, (2016), Journal of Clinical Microbiology, 54, 2470 - 2484

T Cell Functionality in Chronic Hepatitis C Patients Treated With the Anti-miR-122 RG-101


Stelma F. et al, (2016), HEPATOLOGY, 64, 731A - 731A

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans

Journal article

Kelly C. et al, (2016), Hepatology, 63, 1455 - 1470

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR

Journal article

Bonsall D. et al, (2016), Emerging Infectious Diseases, 22, 671 - 678

Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes

Journal article

Kelly C. et al, (2015), European Journal of Immunology, 45, 309 - 316

Global distribution and prevalence of hepatitis C virus genotypes

Journal article

Messina JP. et al, (2015), Hepatology, 61, 77 - 87

Load More